SGLT2 Inhibitors Linked to Lower Epilepsy Risk - Poll - MDSpire

SGLT2 Inhibitors Linked to Lower Epilepsy Risk

Real-world cohort data show lower epilepsy risk vs DPP-4 inhibitors in older patients with type 2 diabetes

  • By

  • Kathryn Wighton

  • April 7, 2026

  • 3 min

Share

Original Source(s)

SGLT2 Inhibitors Linked to Lower Epilepsy Risk

  • by Kathryn Wighton

  • April 7, 2026

Related Content

Acupuncture therapy for post-stroke spasticity: a systematic review and exploratory network meta-analysis of clinical efficacy and dose–response relationship

Editorial: Emerging trends in moyamoya disease: diagnostic and therapeutic innovations

Analysis of risk factors for hemorrhagic transformation after mechanical thrombectomy in acute anterior circulation large vessel occlusion stroke and construction of a nomogram prediction model